Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2026
Sino Biopharmaceutical launches new global brand SBP Group
Sino Biopharmaceutical Limited announced the launch of a new global brand, SBP Group, at its interim results briefing. SBP stands for Science, Breakthroughs and Patients, and the unified brand identity reflects the company's strategic evolution from a leading domestic biopharmaceutical company toward a global innovator.
2020
Sinovac secures $515 million investment to support CoronaVac development and production
Sino Biopharmaceutical said a business unit would invest $515 million in Sinovac Life Sciences to help develop and produce CoronaVac. The investment would give Sino Biopharmaceutical a 15.03% interest in Sinovac Life Sciences.
2020
Sinovac secures approximately $500 million in funding for COVID-19 vaccine development
Sinovac Biotech said it had secured approximately $500 million in funding for COVID-19 vaccine development. The company identified Sino Biopharmaceutical Ltd. as the investor.
2020
Sino Biopharmaceutical obtains drug registration approval
Sino Biopharmaceutical reported that moxifloxacin hydrochloride and sodium chloride injection obtained drug registration approval from China’s National Medical Products Administration.